US 11473060
Compositions and methods for differentiating stem cells into NK cells
granted A61KA61K40/15A61K40/42
Quick answer
US patent 11473060 (Compositions and methods for differentiating stem cells into NK cells) held by CRISPR THERAPEUTICS AG expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K40/15, A61K40/42